Related Experiment Video
Updated: Jun 4, 2025

13:08
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
18.9K
Rare Inherited Coagulation Deficiencies: A Single-center Study
Özlem Terzi1, Sadik Sami Hatipoğlu2
1Pediatric Hematology and Oncology Clinic.
Journal of Pediatric Hematology/Oncology
|December 23, 2024
Summary
Rare factor deficiencies (RFD) affect 1 in 1-3 million individuals. This study highlights the importance of genetic counseling and timely diagnosis for managing life-threatening bleeding risks in children with RFD.
Area of Science:
- Hematology
- Genetics
- Pediatrics
Background:
- Rare factor deficiencies (RFD) encompass a spectrum of inherited bleeding disorders affecting coagulation factors.
- These conditions, with a prevalence of 1 in 1,000,000 to 3,000,000, can manifest with mild to severe bleeding symptoms.
- Combined deficiencies, particularly of vitamin K-dependent factors, present a significant clinical challenge.
Purpose of the Study:
- To contribute to the existing literature on rare factor deficiencies.
- To analyze the characteristics and outcomes of children diagnosed with RFD.
Main Methods:
- A retrospective analysis of data from 43 pediatric patients diagnosed with rare factor deficiencies.
- Review of medical records to identify factor types, clinical presentations, and management strategies.
Main Results:
- Factor VII deficiency was the most frequent (n=13), followed by Factor XII (n=9) and Factor X (n=6).
- 16 out of 43 cases involved consanguineous marriages, suggesting a higher prevalence in such populations.
- Effective management strategies included treatment for acute bleeding and prophylaxis for recurrent symptoms.
Conclusions:
- Autosomal recessive inheritance necessitates improved genetic counseling and diagnostic access for families.
- Timely diagnosis and adequate preventive measures are crucial to mitigate the risk of severe, life-threatening hemorrhages.
- Understanding the genetic and environmental factors, such as consanguinity, is vital for comprehensive RFD management.
Related Concept Videos
Disorders of Hemostasis
699
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
699
Anticoagulant Drugs: Low-Molecular-Weight Heparins
608
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
608
Extrinsic and Intrinsic Pathways of Hemostasis
5.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.3K
Coagulation
4.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
4.6K
X-linked Traits
53.4K
In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
53.4K

